About OCR
OCR is a company based in Loos (France) founded in 2011. OCR has raised $2.75 million across 2 funding rounds from investors including Newfund and Nord France Amorçage. OCR offers products and services including Clinical Studies, R&D Services, Histology, and Biobanking. OCR operates in a competitive market with competitors including Zoetis, Ceva, Bio-Sourcing, Phage Lab and Avecho, among others.
- Headquarter Loos, France
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website oncovet-clinical-research.com
- Social LinkedIn
- Total Equity Funding$2.75M (USD)
in 2 rounds
- Latest Funding Round$1.39M (USD), Seed
Sep 2016
- InvestorsNewfund
& 1 more
Products & Services of OCR
OCR offers a comprehensive portfolio of products and services, including Clinical Studies, R&D Services, Histology, and Biobanking.
Conducts trials for veterinary health advancements.
Supports innovation through biobanking and histology.
Performs tissue analysis for veterinary research.
Manages tissue samples for health studies.
Funding Insights of OCR
OCR has successfully raised a total of $2.75M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.39 million completed in September 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.75M
- Total Rounds 2
- Last Round Seed — $1.39M
- First Round $1.35M
(Jan 2014)
- Investors Count 2
All 2 funding rounds of OCR with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2016 | $1.39M | Seed | – | – | |
| Jan 2014 | $1.35M | Seed | – | – | – |
2 investors in total: 2 institutional.
Investors in OCR
OCR has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Newfund and Nord France Amorçage.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage VC firm investing in geographies such as the US & France | – | newfundcap.com | Paris, France | |
A regional co-investment fund for innovative startups is managed. | 2013 | nord-france-amorcage.fr | France |
Investor details for OCR
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of OCR
4 people are tracked at OCR (2 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Agata Rybicka | Head Of Research And Development | Leadership |
Dominique TIERNY | CEO | Leadership |
Fanny Lepretre | Directeur Des Opérations | Team |
Aylin Aki | Clinical Research Associate Monitor | Team |
Complete people profiles for OCR
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of OCR
3 dated milestones of OCR across 5 years, from founding to its latest funding, stage changes and deals.
- Founded OCR is founded.
- Funding First funding round of $1.4M.
- Funding Latest funding round, Seed, of $1.4M.
Competitors of OCR
OCR operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zoetis, Ceva, Bio-Sourcing, Phage Lab and Avecho, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| zoetis.com | 2012 | Brussels, Belgium | – | 9,200 | Animal medicines, vaccines, and diagnostics are manufactured and supplied. | |
| ceva.com | 1999 | Libourne, France | $214.35M | – | Animal health therapeutics are developed and supplied globally by Ceva. | |
| bio-sourcing.com | 2014 | Liege, Belgium | $17.36M | – | Biopharmaceuticals for animals are manufactured and supplied through partnerships. | |
| phage-lab.com | 2010 | Macul, Chile | $41M | – | Bacteriophage treatments for animal infections are developed by the company. | |
| avecho.com.au | 1992 | Notting Hill, Australia | – | – | Developer of a drug delivery system for the safety of the animal and human health | |
| aquiloncyl.com | 2012 | Leon, Spain | $3.79M | – | Products enhancing animal productivity are developed and marketed. | |
| proteonpharma.com | 2005 | Lodz, Poland | $28.79M | – | Therapeutics for animal infectious diseases are developed via phage platforms. | |
| animab.com | 2020 | Ghent, Belgium | $13.97M | 3 | Proprietary monoclonal antibody platform is provided for pig intestinal infections. | |
| farmpharma.se | 2018 | Uppsala, Sweden | – | – | Therapies for cattle infections are developed using interferon proteins. |
Detailed competitors of OCR
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ocr
Complete news archive for OCR
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to OCR
10 companies that operate in the same segment as OCR (Veterinary Digital Health), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Practice and prescription management software is provided for veterinary professionals. | 2010 | Portland, Oregon, United States | USD 291.64 M | – | – | |
Animal medicines, vaccines, and diagnostics are manufactured and supplied. | 2012 | Brussels, Brussels-capital Region, Belgium | – | – | – | |
Veterinary pharmacy services are delivered by VetSource to practices. | 2005 | Portland, Oregon, United States | USD 81.25 M | – | – | |
Animal health therapeutics are developed and supplied globally by Ceva. | 1999 | Libourne, Nouvelle-aquitaine, France | USD 214.35 M | – | – | |
Digital platform for pet insurance | 2020 | Stockholm, Sweden | USD 114.08 M | – | – | |
App based platform providing veterinary services and clinical management solutions for veterinarians | 2018 | Beverly Hills, California, United States | USD 58.81 M | – | – | |
Online client communication platform for veterinary doctors | 2013 | San Diego, California, United States | USD 14.11 M | USD 14.38 M | 1 | |
Virtual veterinary care is provided via an app platform. | 2018 | Los Angeles, California, United States | USD 210 M | – | 163 | |
Comprehensive customer engagement platform for veterinary clinics is provided. | 2015 | Austin, Texas, United States | USD 50.3 M | – | – | |
Veterinary appointments are booked via an online platform. | 2017 | Brooklyn, New York, United States | USD 243 M | – | 64 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about OCR
OCR was founded in 2011 and raised its 1st funding round 3 years after it was founded.
OCR is headquartered in Loos, France. It is registered at Loos, Nord, France.
OCR is a funded company, having raised a total of $2.75M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.35M, raised on Jan 2014.
Manufacturer of medicines nutraceutical products for pet health. The company is involved in the development of drugs or therapeutic solutions for oncology, inflammation, cardiology, neurology, dermatology, pain more. It offers R D based services and biobank research tool for the identification of multiple diseases such as head neck carcinoma, soft tissue sarcomas, and more.
OCR's top competitors include Zoetis, Ceva and Bio-Sourcing.
OCR offers Clinical Studies, R&D Services, Histology, and Biobanking.
OCR has 2 investors. Key investors include Newfund, and Nord France Amorçage.